🇺🇸 FDA
Patent

US 9605044

Methods and compositions for modulating immune tolerance

granted A61KA61K38/195A61K38/45

Quick answer

US patent 9605044 (Methods and compositions for modulating immune tolerance) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/195, A61K38/45, A61K38/465, A61K45/06